CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

January 9, 2017 · Other

MNKD Other: a negative outcome, -5.6%

On January 9, 2017, biphasic insulin aspart — MannKind Corporation (Diabetes) reached its Other. The result was a negative outcome, and the stock moved -5.6% in the window around the event.

The move

$3.34
1d before
$3.15
Event day
$3.21
1d after
$3.43
5d after

Pre-catalyst setup

+3.2%
30-day run-up
12050%
30-day volatility
0.5×
volume spike